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Abstract
Background: The objective of this study was to determine the concordance rate between core
needle biopsy (CNB) and surgical excision of invasive breast cancer regarding the oestrogen
receptor (ER) and Progesterone receptor (PgR) status as determined by Immunohistochemistry
(IHC).
Methods: Hormone receptor status was established using IHC (using quickscore system 0–8) on
preoperative CNB and subsequent surgical excision in 93 patients with invasive breast cancer.
Results were compared taking into account tumour's size, grade, and patient's age.
Results:  The ER concordance rate between CNB and surgical excisions was 95%. The PgR
concordance rate was 89%. This shows that CNB has a sensitivity of 97% for ER and 95% for PgR.
There is a positive correlation of ER and PgR between CNB and surgical excision (p < 0.000001).
There was no significant difference in the number of core biopsies between concordant and
discordant cases.
Conclusion: Preoperative core biopsy is highly sensitive for the IHC detection of ER and PgR in
invasive breast cancer. The concordance rate is higher for ER than PgR, which could be due to the
fact that ER is more homogeneously distributed.
Introduction
The core needle biopsy (CNB) is technique increasingly
used for the preoperative assessment of breast lesions [1].
Image guidance increases accuracy and reduces the
number of false negative cases [2]. The presence of malig-
nancy and tumour's type and grade are routinely reported.
There is an increasing need to provide prognostic data on
CNB in order to improve treatment outcome [3,4].
Hormone receptor status, and especially ER, provides val-
uable prognostic information and predicts the response to
adjuvant and neo-adjuvant systemic treatment [5].
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Traditionally, the hormone receptor status was deter-
mined by enzyme immunoassay of ER and PgR proteins.
However, this has been replaced gradually by immunohis-
tochemistry (IHC), which has shown an equal reliability
[6].
Previous studies that examined the reliability of preoper-
ative CNB using enzyme immunoassay showed conflict-
ing results [7-9].
This retrospective study examines the correlation between
CNB and surgical excision in regards to the ER ad PgR sta-
tus of invasive breast cancer using IHC.
Patients and Methods
In this retrospective study we looked at consecutive 95
cases of invasive breast carcinoma in 93 patients. All
patients underwent CNB at their clinic appointment and
proceeded for breast surgery subsequently 2–3 weeks
later. Preoperative CNBs and surgical excision specimens
were analysed for ER and PgR status using IHC (DAKO
mab) after antigen retrieval at high temperature. All spec-
imens were analysed using semi quantitative IHC "quick
score" system (0 – 8) by the same breast pathologist. With
this method, the intensity of the immunohistochemical
reaction as viewed under the light microscope was
recorded 0–4 (0 indicated no staining of any nuclei even
at high magnification). The proportion of cells staining
positively at any intensity was scored as 0 (no cell stain-
ing), 1 (1–25% cells stained), 2 (26–50% cells stained), 3
(51–75% cells stained) or 4 (when >75% cells stained).
The proportion and intensity scores were added together
to obtain a total score ranging from 0 to 8.
We also examined other parameters including: tumour
size, grade, and patient's age.
ER/PgR status was considered positive if quick score was 2
– 8. Results were re-assessed when quick score was raised
to 4 – 8 to label ER/PgR status as positive. The number of
biopsies taken on each occasion was also recorded.
Results
The mean and median age of this study group was 59.2
and 59 respectively (range 32 – 92 years). The mean
tumour size was 20 mm (3.2 – 110 mm), and the median
Graphic Results, 1: ER in CNB, 2: ER in surgical excision Figure 1
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grade was 2 (1 – 3). The median number of CNBs taken at
preoperative assessment was 2.6 (1 – 9). The mean IHC
score for ER was 6.7 (range 0 – 8).
All patients had either mastectomy or lumpectomy as
their definitive surgical treatment.
Firstly, ER/PgR status was considered positive if quick
score was 2 – 8. The concordance for tumour grade was
65%. The concordance rate for ER was 95% between CNB
and surgical excision. There were 2 false negative and 3
false positive cases. PgR concordance rate was 89% with 4
false negative and 6 false positive cases. According to the
above results the sensitivity of CNB for ER and PgR was
97% and 95% respectively. Furthermore, to re-examine
our findings, we analysed the results considering ER/PgR
to be positive if quick score was 4 – 8. We found a con-
cordance rate for ER to be 93% (3 false negative and 5
false positive cases). The concordance rate for PgR was
92% (3 false negative and 6 false positive cases) (figure 1).
This gives CNB sensitivity of 98% for positive ER status
and 96% for positive PgR status (table 1).
ER in CNB positively correlated with ER in surgical exci-
sion (r: 0.61, p < 0.000001). PgR in CNB also positively
correlated with PgR in surgical excision (r: 0.66, p <
0.000001)
There was no significant difference in the number of CNBs
between concordant and discordant cases.
Discussion
Core needle biopsies offer a reliable and accurate assess-
ment of hormone receptor status.
Previous studies on a smaller case sample have suggested
similar findings regarding ER [10-12]. However, results on
PgR were less consistent.
The concordance rate in our study for ER was higher than
for PgR. Homogenous distribution of ER through out the
tumour is a possible explanation. Heterogeneity of the ER
in tumour cell populations may have important implica-
tions for analytic cell selection and for prognosis in ER-
positive carcinomas. Previous studies have shown
homogenous geographic distribution of ER in the tumour
cell population [13,14].
These results indicate that the hormone receptor status as
determined by CNB can be reliably used to guide neo-
adjuvant and adjuvant systemic therapy in patients with
invasive breast cancer.
In summary, preoperative CNB is highly sensitive for the
IHC detection of ER and PgR in invasive breast cancer.
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Table 1: Sensitivity and specificity of CNB for ER and PgR 
Status.
Parameter ER status N = 95 PgR status N = 93
Positive CNB 89 85
Negative CNB 6 8
Positive SE 86 82
Negative SE 9 11
Sensitivity of CNB 97.6% 96.3%
Specificity of CNB 96.6% 96.4%
Concordance rate 92.6% 92.4%
CNB: Core Needle Biopsy
SE: Surgical Excision
Positive: Quickscore 4 – 8
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